Salvage lymph node dissection with adjuvant radiotherapy for Choline-PET-CT positive lymph node metastases in patients with nodal recurrence of prostate cancer

Salvage lymph node dissection with adjuvant radiotherapy for Choline-PET-CT positive lymph node metastases in patients with nodal recurrence of prostate cancer - Salvage lymphadenectomy for nodal prostate cancer recurrence

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003472

Enrollment

Registered

2012-05-29

Start date

2012-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61 C77

Interventions

Group 1: salvage lymph node dissection with adjuvant radiotherapy

Eligibility

Sex/Gender

Male

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with biochemical relapse after radical prostatectomy or primary radiotherapy, evidence (11C-choline or 18F-fluorethylcholin-PET-CT) for nodal recurrence of PCA , Charlson-Comorbidity-index = 2, age <80 years.

Exclusion criteria

Exclusion criteria: Presence of bone or visceral metastases, Charlson-Comorbidity-index > 2, age > 80 years, presence of untreated local recurrence in prostatic fossa, continuation of anti hormonal therapy

Design outcomes

Primary

Measure	Time frame
PSA-progression free survival	—

Secondary

Measure	Time frame
clinical progression of prostate cancer tumor specific and overall survival	—

Countries

Germany

Contacts

Public ContactCordula Jilg

Universitätsklinikum Freiburg, Urologische Klinik

cordula.jilg@uniklinik-freiburg.de0761/270-28920

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026